About CTOP


The Cellular Therapy Operations Program (CTOP) is a team of experienced clinical research professionals that support investigator-initiated clinical trials testing therapeutic agents produced at the Gates Biomanufacturing Facility (GBF).

CTOP works on behalf of CU Anschutz, acting as the sponsor team, and is comprised of a Scientific and Medical Director, Regulatory and Operations Director, Project Manager, Pharmacovigilance Specialist, and Protocol Development Specialist. The team works closely with the PI, study team, GBF, and the Office of Regulatory Compliance to develop and operationalize cell therapy clinical trials.

CTOP Mission


The mission of CTOP is to partner with CU Anschutz investigators and stakeholders to develop innovative Cellular Therapies and facilitate the regulatory and operational conduct of clinical trials.

CTOP Roles


Clinical Trial Protocol Development

FDA IND Submission

strategy and materials

Project Timelines Management

manufacturing and regulatory milestones

Comprehensive Sponsor Budget Development

Regulatory Submission

materials for scientific and ethical review (PRMS, IBC, IRB)

Pharmacovigilance Oversight Plans

Frequently Asked Questions (FAQ)